Ustekinumab - PDFSEARCH.IO - Document Search Engine

Ustekinumab
Results: 77

#	Item
51	CLINICAL REVIEW Division of Clinical Evaluation, Office of Cellular Tissue and Gene Therapy, Center for Biologics Evaluation and Research ________________________________________________________________________ TITLE AND Add to Reading List Source URL: www.fda.gov Language: English Biology Clinical trial FDA Special Protocol Assessment Food and Drug Administration Cell therapy Pharmacovigilance ArteFill Ustekinumab Pharmaceutical sciences Pharmacology Clinical research
52	Janssen Biotech Inc. Sharps Disposal Plan Add to Reading List Source URL: www.calrecycle.ca.gov Language: English - Date: 2014-07-17 18:08:51 Medical equipment Medical ethics Immunosuppressants Monoclonal antibodies Ustekinumab Golimumab Johnson & Johnson Medical waste Stericycle Medicine Centocor Pharmacology
53	Mid-Cycle Memo - Isolagen Treatment Add to Reading List Source URL: www.fda.gov Language: English Science Research Bioethics Medical ethics Design of experiments Placebo Clinical trial Ustekinumab Sertraline Medicine Clinical research Pharmacology
54	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA® safely and effectively. See full prescribing information for STELARA®. STELARA® (ustekinumab) injection, Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-06-05 17:00:34 Ustekinumab Medicine Psoriasis Anakinra Immunosuppressants Monoclonal antibodies Centocor
55	United States Court of Appeals for the Federal Circuit ______________________ ABBVIE DEUTSCHLAND GMBH & CO., KG, ABBVIE BIORESEARCH CENTER, INC., AND Add to Reading List Source URL: www.patents4life.com Language: English - Date: 2014-07-07 10:21:43 Centocor Immunosuppressants Monoclonal antibodies Law Ustekinumab Declaratory judgment Antibody Prior art Patent infringement Biology Glycoproteins Immune system
56	Wilcox Pharmacy/Option Care Respiratory Syncytial Virus (RSV) Prophylaxis Add to Reading List Source URL: dvha.vermont.gov Language: English - Date: 2014-06-03 15:08:15 Monoclonal antibodies Clinical pharmacology Medical prescription Patient safety Ustekinumab Adalimumab Syringe Etanercept Pharmacology Immunosuppressants Medicine
57	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STELARA® safely and effectively. See full prescribing information for STELARA®. STELARA® (ustekinumab) injection, Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2013-05-23 16:04:31 Ustekinumab Medicine Psoriasis Immunosuppressive drug Anakinra Alefacept Immunosuppressants Monoclonal antibodies Centocor
58	Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement Add to Reading List Source URL: www.janssen.com Language: English - Date: 2014-07-31 20:38:04 Piperazines Centocor Immunosuppressants Monoclonal antibodies Amines Tapentadol Ustekinumab Infliximab Levofloxacin Chemistry Pharmacology Medicine
59	CDER New Molecular Entity (NME)/ New BLA Calendar Year Approvals As of December 31, 2009 Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Centocor Ustekinumab Celgene Febuxostat Pharmacology Chemistry Organic chemistry Carboxylic acids
60	Original Article JOURNAL OF WOMEN’S HEALTH Volume 22, Number 7, 2013 ª Mary Ann Liebert, Inc. DOI: [removed]jwh[removed] Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Pharmaceutical industry Research Clinical research Drug discovery New Drug Application Clinical trial Drug development Ustekinumab Pharmaceutical sciences Food and Drug Administration Health